HOLISTA COLLTECH LIMITED – Trademark Portfolio
Entity Type: 16
HOLISTA COLLTECH LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GILITE, OVICOLL, and PROTECTENE ANTI-PATHOGEN SOLUTION. The owner is based in Subiaco WA.
283, Rokeby Road
Subiaco WA 6008 , AU
Showing of trademarks Trademarks
Trademark Classifications
HOLISTA COLLTECH LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does HOLISTA COLLTECH LIMITED have?
HOLISTA COLLTECH LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does HOLISTA COLLTECH LIMITED file in?
HOLISTA COLLTECH LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are HOLISTA COLLTECH LIMITED's most well-known trademarks?
HOLISTA COLLTECH LIMITED's registered trademark portfolio includes well-known marks such as GILITE, OVICOLL, and PROTECTENE ANTI-PATHOGEN SOLUTION. These are among 3 currently registered trademarks in the portfolio.
What is HOLISTA COLLTECH LIMITED's trademark registration success rate?
HOLISTA COLLTECH LIMITED has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.